Truepoint, Inc. Bristol Myers Squibb CO Transaction History

Truepoint, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $190,380 - $227,176	3,927 New	3,927 $201,000
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $248,941 - $274,171	-3,428 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $24,592 - $29,488	-400 Reduced 10.45%	3,428 $250,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $1,555 - $1,813	29 Added 0.76%	3,828 $239,000
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $6,272 - $7,346	106 Added 2.87%	3,799 $225,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $228,633 - $248,982	3,693 New	3,693 $247,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

Stay updated on Truepoint, Inc. with notifications on news.